What specific risks are people who use drugs (PWUD) likely to face during the COVID-19 pandemic? What services will they need? How will professionals working with this group adapt on the frontline? These are among the questions raised and answered in a new EMCDDA briefing.
The briefing offers information about:
- Context – the coronavirus outbreak (COVID-19) in the EU
- What are the particular risks for people who use drugs (PWUD) during the COVID-19 pandemic?
- Underlying chronic medical conditions are associated with some forms of drug use and increase the risk of developing severe illnesses
- The risk of drug overdose may be increased among PWUD who are infected with COVID-19
- Sharing drug-using equipment may increase the risk of infection
- Crowded environments increase the risk of exposure to COVID-19
- Risks of disruption in access to drug services, clean drug-using equipment and vital medications
- Implementing prevention measures against transmission of COVID-19 in settings used by PWUD
- Guaranteeing continuity of care during the pandemic
- Ensuring service continuity
- Service provider protection during the pandemic – important interventions to consider
The briefing is available at the EMCDDA website following this link>>>